Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01832883 · ClinicalTrials.gov registry record
Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner
A clinical trial, sponsored by Rebiscan.
- Completed
- Registry status
- 78
- Enrollment target
NCT01832883: Completed study, sponsored by Rebiscan.
NCT01832883 is a clinical trial that has completed, run by Rebiscan. The registered enrollment target is 78 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01832883 has completed, sponsored by Rebiscan.
- COMPLETED
- Registry status
- 78 participants
- Enrollment target
Study Summary
The purpose of this project is to compare the performance of the Pediatric Vision Scanner (PVS) with the Gold Standard Examination to determine the effectiveness of the PVS at detecting amblyopia and strabismus.
Interventions
- DEVICE Pediatric Vision Scanner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-07 |
What the finished NCT01832883 record still lists
NCT01832883 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 78 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pediatric Vision Scanner is the first listed.
NCT01832883 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01832883 about?
NCT01832883 is a clinical study titled "Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner". The purpose of this project is to compare the performance of the Pediatric Vision Scanner (PVS) with the Gold Standard Examination to determine the effectiveness of the PVS at detecting amblyopia and strabismus.
What is the current status of trial NCT01832883?
This trial is currently completed. The enrollment target is 78 participants. The study started on 2010-12. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01832883?
The interventions under investigation include: Pediatric Vision Scanner (DEVICE).
Who is sponsoring clinical trial NCT01832883?
This trial is sponsored by Rebiscan, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia